Trial Profile
Effect of fampridine on walking ability in patients with neuromyelitis optica ( NMO) and walking impairment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2015
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Neuromyelitis optica
- Focus Therapeutic Use
- 16 Jun 2015 New trial record
- 25 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology.